がん性疼痛市場レポート：2031年までの動向、予測、競合分析

世界のがん性疼痛市場は、放射線療法、化学療法、ホルモン療法市場に機会があり、将来性が期待されます。世界のがん性疼痛市場は、2025年から2031年にかけてCAGR 5.1％で成長すると予想されます。この市場の主な促進要因は、腫瘍サイズの増大と周辺組織への圧迫、他の臓器へのがんの広がりの増加です。

• Lucintel社の予測によると、タイプ別ではオピオイドが予測期間中に高い成長を遂げる見込みです。
• 用途別では、化学療法が最も高い成長が見込まれます。
• 地域別では、APACが予測期間中に最も高い成長が見込まれます。

150ページ超の包括的な本レポートで、ビジネス上の意思決定に役立つ貴重な洞察を得られます。いくつかの洞察を含むサンプル図を以下に示します。

がん性疼痛市場の新たな動向

がん性疼痛市場の新興動向は、治療法の開発、提供、アクセス方法を形成しています。これらの動向は、より効果的で個別化された、利用しやすい疼痛管理ソリューションに対するニーズの高まりを反映しています。製薬研究の革新、技術の進歩、患者ケアのシフトが市場の進化を促しています。以下は、がん疼痛管理の展望を変えつつある5つの主要動向です。

• オピオイド代替薬と非薬理療法：オピオイド依存や副作用への懸念が高まる中、がん疼痛管理における非オピオイド代替療法へのシフトが進んでいます。これには、ガバペンチノイドや抗うつ薬などの薬物療法や、鍼治療、理学療法、認知行動療法などの非薬物療法が含まれます。これらの治療は、オピオイドに伴うリスクを伴わずに効果的な鎮痛を提供することを目的としています。
• 個別化された疼痛管理：患者の疼痛体験や治療への反応は千差万別であるため、個別化された疼痛管理は重要なトレンドになりつつあります。先進的な診断ツールや遺伝子プロファイリングにより、臨床医は個々のニーズに応じた治療を行えるようになってきています。個別化されたアプローチは、疼痛緩和を改善し副作用を最小限に抑え、がん性疼痛に対してより的を絞った効果的な解決策を提供すると期待されています。
• ドラッグデリバリーの技術革新：経皮吸収パッチ、徐放性製剤、マイクロカプセル化技術などの新しいドラッグデリバリーシステムは、がん疼痛管理に革命をもたらしています。これらの技術革新により、継続的な疼痛緩和が可能になり、頻繁な投与の必要性が減り、患者の利便性が向上しています。さらに、これらの高度なシステムは、鎮痛薬の血中濃度を安定させ、有効性と患者の転帰を改善するのに役立ちます。
• 緩和ケアへの関心の高まり：がんの診断が世界的に増加するにつれ、疼痛管理を中核とする緩和ケアへの注目が高まっています。緩和ケアは、身体的な痛みだけでなく、感情的、心理的、社会的なニーズにも対応することで、患者の生活の質を向上させることを目的としています。ヘルスケア提供者や政策立案者は、がん患者の複雑なニーズに対応するため、緩和ケアプログラムやサービスの開発を優先しています。
• 在宅ケアへのシフト：在宅ケアはがん疼痛管理において勢いを増しています。遠隔医療、在宅医療サービス、携帯型疼痛管理機器の進歩により、患者は自宅で効果的な治療を受けられるようになっています。このシフトにより、入院期間が短縮され、医療費が削減され、患者は治療中も自宅で快適に過ごすことができ、全体的な患者の満足度と生活の質が向上します。

こうした動向は、より多様で個別化されたソリューションを提供することで、がん疼痛市場を再構築しています。オピオイドからの脱却、ドラッグデリバリー技術の進歩、全人的ケアへの注目は、患者の転帰と満足度を向上させています。さらに、在宅ケアや緩和ケアモデルへの移行は、世界のがん負担の増大に対処する上で極めて重要なアクセシビリティとアフォーダビリティを高めています。

がん疼痛市場の最近の動向

がん性疼痛市場は、技術の進歩、革新的な治療法、進化するヘルスケア政策によって大きな変化を遂げつつあります。こうした開発により、がん疼痛の管理が強化され、効果的な治療へのアクセスが拡大しています。以下は、がん疼痛市場の成長と方向性に影響を与えている5つの主な発展です。

• 非オピオイド系疼痛管理選択肢の開発：オピオイドの使用に伴うリスクに対する認識の高まりにより、オピオイドを使用しない疼痛管理の選択肢が開発されています。こうした代替薬には神経ブロック治療、神経成長因子阻害薬、カンナビノイドなどがあり、副作用が少なく効果的な鎮痛を提供しています。こうした選択肢への移行は、オピオイド依存を減らし、がん患者の疼痛管理全般を改善すると期待されています。
• 疼痛管理機器の進歩：技術革新により、神経刺激や脊髄刺激装置などの高度な疼痛管理装置が開発されています。これらの機器は難治性のがん性疼痛の治療に使用されており、患者に従来の薬物療法以上の選択肢を提供しています。これらの機器の普及は、疼痛管理への個別化アプローチに貢献しています。
• 疼痛管理アクセスにおける規制の改善：米国や欧州を含むいくつかの地域では、がん疼痛管理ソリューションへのアクセスを改善するための規制改革が実施されています。オピオイドへのアクセス拡大、非オピオイドの新規治療法の承認、償還制度の強化に重点を置いた政策により、患者が必要な治療を受けやすくなっています。
• 併用療法の革新：薬理学的治療と非薬理学的介入を組み合わせた併用療法の動向が活発化しています。このような治療法はがん疼痛の複数の側面に対処し、患者により包括的な治療選択肢を提供します。例えば、オピオイド薬と鍼治療や理学療法を併用することで、疼痛緩和を強化し、生活の質を改善することができます。
• 疼痛管理における遠隔医療の統合：遠隔医療は、ヘルスケアプロバイダーが遠隔で患者をモニターし、治療計画をリアルタイムで調整できるようにすることで、がん疼痛管理に変革をもたらしつつあります。この開発は、特に地方や十分なサービスを受けていない地域の患者にとって有益であり、疼痛管理をより身近なものにしています。遠隔医療の統合はまた、患者の治療への関与とコンプライアンスを向上させる。

これらの主な発展は、より効果的で個別化された、利用しやすい治療法を提供することで、がん疼痛管理の状況を向上させています。その結果、患者はより良い痛みの緩和と生活の質の向上を経験し、ヘルスケアシステムはより費用対効果の高いソリューションから利益を得ています。

目次

第1章 エグゼクティブサマリー

第2章 世界のがん性疼痛市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• PESTLE分析
• 特許分析
• 規制環境
• 業界の促進要因と課題

第3章 2019年から2031年までの市場動向と予測分析

• マクロ経済動向（2019年～2024年）と予測（2025年～2031年）
• 世界のがん性疼痛市場の動向（2019年～2024年）と予測（2025年～2031年）
• 世界のがん性疼痛市場：タイプ別
  • オピオイド：動向と予測（2019～2031年）
  • 非ステロイド性抗炎症薬：動向と予測（2019～2031年）
  • その他：動向と予測（2019～2031年）
• 世界のがん性疼痛市場：用途別
  • 放射線治療：動向と予測（2019～2031年）
  • 化学療法：動向と予測（2019～2031年）
  • ホルモン療法：動向と予測（2019～2031年）
  • その他：動向と予測（2019～2031年）

第4章 2019年から2031年の地域別市場動向と予測分析

• 地域別の世界のがん性疼痛市場
• 北米のがん性疼痛市場
• 欧州のがん性疼痛市場
• アジア太平洋のがん性疼痛市場
• その他地域のがん疼痛市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析
  • 競争企業間の敵対関係
  • 買い手の交渉力
  • 供給企業の交渉力
  • 代替品の脅威
  • 新規参入業者の脅威

第6章 成長機会と戦略分析

• 成長機会分析
  • 世界のがん性疼痛市場におけるタイプ別成長機会
  • 世界のがん性疼痛市場における用途別の成長機会
  • 地域別世界のがん性疼痛市場の成長機会
• 世界のがん性疼痛市場における新たな動向
• 戦略分析
  • 新製品開発
  • 世界のがん性疼痛市場のキャパシティ拡大
  • 世界のがん性疼痛市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 主要企業の企業プロファイル

• BioDelivery Science
• ProStrakan Group
• Teva Pharmaceuticals
• Eli-Lilly
• Grunenthal Group
• GW Pharmaceuticals
• Johnson&Johnson
• Meda Pharmaceuticals
• Orexo
• Sanofi

List of Figures

• Figure 2.1: Classification of the Global Cancer Pain Market
• Figure 2.2: Supply Chain of the Global Cancer Pain Market
• Figure 3.1: Trends of the Global GDP Growth Rate
• Figure 3.2: Trends of the Global Population Growth Rate
• Figure 3.3: Trends of the Global Inflation Rate
• Figure 3.4: Trends of the Global Unemployment Rate
• Figure 3.5: Trends of the Regional GDP Growth Rate
• Figure 3.6: Trends of the Regional Population Growth Rate
• Figure 3.7: Trends of the Regional Inflation Rate
• Figure 3.8: Trends of the Regional Unemployment Rate
• Figure 3.9: Trends of Regional Per Capita Income
• Figure 3.10: Forecast for the Global GDP Growth Rate
• Figure 3.11: Forecast for the Global Population Growth Rate
• Figure 3.12: Forecast for the Global Inflation Rate
• Figure 3.13: Forecast for the Global Unemployment Rate
• Figure 3.14: Forecast for the Regional GDP Growth Rate
• Figure 3.15: Forecast for the Regional Population Growth Rate
• Figure 3.16: Forecast for the Regional Inflation Rate
• Figure 3.17: Forecast for the Regional Unemployment Rate
• Figure 3.18: Forecast for Regional Per Capita Income
• Figure 3.19: Global Cancer Pain Market by Type in 2019, 2024, and 2031 ($Billion)
• Figure 3.20: Trends of the Global Cancer Pain Market ($B) by Type (2019-2024)
• Figure 3.21: Forecast for the Global Cancer Pain Market ($B) by Type (2025-2031)
• Figure 3.22: Trends and Forecast for Opioids in the Global Cancer Pain Market (2019-2031)
• Figure 3.23: Trends and Forecast for Non-Steroidal Anti-Inflammatory Drugs in the Global Cancer Pain Market (2019-2031)
• Figure 3.24: Trends and Forecast for Others in the Global Cancer Pain Market (2019-2031)
• Figure 3.25: Global Cancer Pain Market by Application in 2019, 2024, and 2031 ($Billion)
• Figure 3.26: Trends of the Global Cancer Pain Market ($B) by Application (2019-2024)
• Figure 3.27: Forecast for the Global Cancer Pain Market ($B) by Application (2025-2031)
• Figure 3.28: Trends and Forecast for Radiotherapy in the Global Cancer Pain Market (2019-2031)
• Figure 3.29: Trends and Forecast for Chemotherapy in the Global Cancer Pain Market (2019-2031)
• Figure 3.30: Trends and Forecast for Hormone Therapy in the Global Cancer Pain Market (2019-2031)
• Figure 3.31: Trends and Forecast for Others in the Global Cancer Pain Market (2019-2031)
• Figure 4.1: Trends of the Global Cancer Pain Market ($B) by Region (2019-2024)
• Figure 4.2: Forecast for the Global Cancer Pain Market ($B) by Region (2025-2031)
• Figure 4.3: Trends and Forecast for the North American Cancer Pain Market (2019-2031)
• Figure 4.4: North American Cancer Pain Market by Type in 2019, 2024, and 2031 ($Billion)
• Figure 4.5: Trends of the North American Cancer Pain Market ($B) by Type (2019-2024)
• Figure 4.6: Forecast for the North American Cancer Pain Market ($B) by Type (2025-2031)
• Figure 4.7: North American Cancer Pain Market by Application in 2019, 2024, and 2031 ($Billion)
• Figure 4.8: Trends of the North American Cancer Pain Market ($B) by Application (2019-2024)
• Figure 4.9: Forecast for the North American Cancer Pain Market ($B) by Application (2025-2031)
• Figure 4.10: Trends and Forecast for the United States Cancer Pain Market (2019-2031)
• Figure 4.11: Trends and Forecast for the Mexican Cancer Pain Market (2019-2031)
• Figure 4.12: Trends and Forecast for the Canadian Cancer Pain Market (2019-2031)
• Figure 4.13: Trends and Forecast for the European Cancer Pain Market (2019-2031)
• Figure 4.14: European Cancer Pain Market by Type in 2019, 2024, and 2031 ($Billion)
• Figure 4.15: Trends of the European Cancer Pain Market ($B) by Type (2019-2024)
• Figure 4.16: Forecast for the European Cancer Pain Market ($B) by Type (2025-2031)
• Figure 4.17: European Cancer Pain Market by Application in 2019, 2024, and 2031 ($Billion)
• Figure 4.18: Trends of the European Cancer Pain Market ($B) by Application (2019-2024)
• Figure 4.19: Forecast for the European Cancer Pain Market ($B) by Application (2025-2031)
• Figure 4.20: Trends and Forecast for the German Cancer Pain Market (2019-2031)
• Figure 4.21: Trends and Forecast for the French Cancer Pain Market (2019-2031)
• Figure 4.22: Trends and Forecast for the Spanish Cancer Pain Market (2019-2031)
• Figure 4.23: Trends and Forecast for the Italian Cancer Pain Market (2019-2031)
• Figure 4.24: Trends and Forecast for the United Kingdom Cancer Pain Market (2019-2031)
• Figure 4.25: Trends and Forecast for the APAC Cancer Pain Market (2019-2031)
• Figure 4.26: APAC Cancer Pain Market by Type in 2019, 2024, and 2031 ($Billion)
• Figure 4.27: Trends of the APAC Cancer Pain Market ($B) by Type (2019-2024)
• Figure 4.28: Forecast for the APAC Cancer Pain Market ($B) by Type (2025-2031)
• Figure 4.29: APAC Cancer Pain Market by Application in 2019, 2024, and 2031 ($Billion)
• Figure 4.30: Trends of the APAC Cancer Pain Market ($B) by Application (2019-2024)
• Figure 4.31: Forecast for the APAC Cancer Pain Market ($B) by Application (2025-2031)
• Figure 4.32: Trends and Forecast for the Japanese Cancer Pain Market (2019-2031)
• Figure 4.33: Trends and Forecast for the Indian Cancer Pain Market (2019-2031)
• Figure 4.34: Trends and Forecast for the Chinese Cancer Pain Market (2019-2031)
• Figure 4.35: Trends and Forecast for the South Korean Cancer Pain Market (2019-2031)
• Figure 4.36: Trends and Forecast for the Indonesian Cancer Pain Market (2019-2031)
• Figure 4.37: Trends and Forecast for the ROW Cancer Pain Market (2019-2031)
• Figure 4.38: ROW Cancer Pain Market by Type in 2019, 2024, and 2031 ($Billion)
• Figure 4.39: Trends of the ROW Cancer Pain Market ($B) by Type (2019-2024)
• Figure 4.40: Forecast for the ROW Cancer Pain Market ($B) by Type (2025-2031)
• Figure 4.41: ROW Cancer Pain Market by Application in 2019, 2024, and 2031 ($Billion)
• Figure 4.42: Trends of the ROW Cancer Pain Market ($B) by Application (2019-2024)
• Figure 4.43: Forecast for the ROW Cancer Pain Market ($B) by Application (2025-2031)
• Figure 4.44: Trends and Forecast for the Middle Eastern Cancer Pain Market (2019-2031)
• Figure 4.45: Trends and Forecast for the South American Cancer Pain Market (2019-2031)
• Figure 4.46: Trends and Forecast for the African Cancer Pain Market (2019-2031)
• Figure 5.1: Porter's Five Forces Analysis for the Global Cancer Pain Market
• Figure 6.1: Growth Opportunities for the Global Cancer Pain Market by Type
• Figure 6.2: Growth Opportunities for the Global Cancer Pain Market by Application
• Figure 6.3: Growth Opportunities for the Global Cancer Pain Market by Region
• Figure 6.4: Emerging Trends in the Global Cancer Pain Market

List of Table

• Table 1.1: Growth Rate (%, 2019-2024) and CAGR (%, 2025-2031) of the Cancer Pain Market by Type and Application
• Table 1.2: Attractiveness Analysis for the Cancer Pain Market by Region
• Table 1.3: Global Cancer Pain Market Parameters and Attributes
• Table 3.1: Trends of the Global Cancer Pain Market (2019-2024)
• Table 3.2: Forecast for the Global Cancer Pain Market (2025-2031)
• Table 3.3: Attractiveness Analysis for the Global Cancer Pain Market by Type
• Table 3.4: Market Size and CAGR of Various Type in the Global Cancer Pain Market (2019-2024)
• Table 3.5: Market Size and CAGR of Various Type in the Global Cancer Pain Market (2025-2031)
• Table 3.6: Trends of Opioids in the Global Cancer Pain Market (2019-2024)
• Table 3.7: Forecast for the Opioids in the Global Cancer Pain Market (2025-2031)
• Table 3.8: Trends of Non-Steroidal Anti-Inflammatory Drugs in the Global Cancer Pain Market (2019-2024)
• Table 3.9: Forecast for the Non-Steroidal Anti-Inflammatory Drugs in the Global Cancer Pain Market (2025-2031)
• Table 3.10: Trends of Others in the Global Cancer Pain Market (2019-2024)
• Table 3.11: Forecast for the Others in the Global Cancer Pain Market (2025-2031)
• Table 3.12: Attractiveness Analysis for the Global Cancer Pain Market by Application
• Table 3.13: Market Size and CAGR of Various Application in the Global Cancer Pain Market (2019-2024)
• Table 3.14: Market Size and CAGR of Various Application in the Global Cancer Pain Market (2025-2031)
• Table 3.15: Trends of Radiotherapy in the Global Cancer Pain Market (2019-2024)
• Table 3.16: Forecast for the Radiotherapy in the Global Cancer Pain Market (2025-2031)
• Table 3.17: Trends of Chemotherapy in the Global Cancer Pain Market (2019-2024)
• Table 3.18: Forecast for the Chemotherapy in the Global Cancer Pain Market (2025-2031)
• Table 3.19: Trends of Hormone Therapy in the Global Cancer Pain Market (2019-2024)
• Table 3.20: Forecast for the Hormone Therapy in the Global Cancer Pain Market (2025-2031)
• Table 3.21: Trends of Others in the Global Cancer Pain Market (2019-2024)
• Table 3.22: Forecast for the Others in the Global Cancer Pain Market (2025-2031)
• Table 4.1: Market Size and CAGR of Various Regions in the Global Cancer Pain Market (2019-2024)
• Table 4.2: Market Size and CAGR of Various Regions in the Global Cancer Pain Market (2025-2031)
• Table 4.3: Trends of the North American Cancer Pain Market (2019-2024)
• Table 4.4: Forecast for the North American Cancer Pain Market (2025-2031)
• Table 4.5: Market Size and CAGR of Various Type in the North American Cancer Pain Market (2019-2024)
• Table 4.6: Market Size and CAGR of Various Type in the North American Cancer Pain Market (2025-2031)
• Table 4.7: Market Size and CAGR of Various Application in the North American Cancer Pain Market (2019-2024)
• Table 4.8: Market Size and CAGR of Various Application in the North American Cancer Pain Market (2025-2031)
• Table 4.9: Trends of the European Cancer Pain Market (2019-2024)
• Table 4.10: Forecast for the European Cancer Pain Market (2025-2031)
• Table 4.11: Market Size and CAGR of Various Type in the European Cancer Pain Market (2019-2024)
• Table 4.12: Market Size and CAGR of Various Type in the European Cancer Pain Market (2025-2031)
• Table 4.13: Market Size and CAGR of Various Application in the European Cancer Pain Market (2019-2024)
• Table 4.14: Market Size and CAGR of Various Application in the European Cancer Pain Market (2025-2031)
• Table 4.15: Trends of the APAC Cancer Pain Market (2019-2024)
• Table 4.16: Forecast for the APAC Cancer Pain Market (2025-2031)
• Table 4.17: Market Size and CAGR of Various Type in the APAC Cancer Pain Market (2019-2024)
• Table 4.18: Market Size and CAGR of Various Type in the APAC Cancer Pain Market (2025-2031)
• Table 4.19: Market Size and CAGR of Various Application in the APAC Cancer Pain Market (2019-2024)
• Table 4.20: Market Size and CAGR of Various Application in the APAC Cancer Pain Market (2025-2031)
• Table 4.21: Trends of the ROW Cancer Pain Market (2019-2024)
• Table 4.22: Forecast for the ROW Cancer Pain Market (2025-2031)
• Table 4.23: Market Size and CAGR of Various Type in the ROW Cancer Pain Market (2019-2024)
• Table 4.24: Market Size and CAGR of Various Type in the ROW Cancer Pain Market (2025-2031)
• Table 4.25: Market Size and CAGR of Various Application in the ROW Cancer Pain Market (2019-2024)
• Table 4.26: Market Size and CAGR of Various Application in the ROW Cancer Pain Market (2025-2031)
• Table 5.1: Market Presence of Major Players in the Global Cancer Pain Market
• Table 5.2: Operational Integration of the Global Cancer Pain Market
• Table 6.1: New Product Launch by a Major Cancer Pain Producer (2019-2024)

The future of the global cancer pain market looks promising with opportunities in the radiotherapy, chemotherapy, and hormone therapy markets. The global cancer pain market is expected to grow with a CAGR of 5.1% from 2025 to 2031. The major drivers for this market are increase in tumor size and pressure on surrounding tissues and the rising spread of cancer to other organs causes.

• Lucintel forecasts that, within the type category, opioids are expected to witness higher growth over the forecast period.
• Within the application category, chemotherapy is expected to witness the highest growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.

Emerging Trends in the Cancer Pain Market

Emerging trends in the cancer pain market are shaping the way treatments are developed, delivered, and accessed. These trends reflect the growing need for more effective, personalized, and accessible pain management solutions. Innovations in pharmaceutical research, technological advancements, and shifts in patient care are driving the evolution of the market. Below are five key trends that are transforming the landscape of cancer pain management.

• Opioid Alternatives and Non-Pharmacological Therapies: With growing concerns about opioid dependence and side effects, there is an increasing shift towards non-opioid alternatives for cancer pain management. These include medications such as gabapentinoids and anti-depressants, as well as non-pharmacological approaches like acupuncture, physiotherapy, and cognitive-behavioral therapy. These treatments aim to provide effective pain relief without the risks associated with opioids.
• Personalized Pain Management: Personalized pain management is becoming a significant trend, as patients' pain experiences and responses to treatments vary greatly. Advanced diagnostic tools and genetic profiling are enabling clinicians to tailor treatments based on individual needs. Personalized approaches are expected to improve pain relief and minimize side effects, offering more targeted and effective solutions for cancer pain.
• Technological Innovations in Drug Delivery: New drug delivery systems, such as transdermal patches, slow-release formulations, and microencapsulation technologies, are revolutionizing cancer pain management. These innovations allow for continuous pain relief, reducing the need for frequent dosing and enhancing patient convenience. Furthermore, these advanced systems can help maintain stable blood levels of pain relief medications, improving efficacy and patient outcomes.
• Growing Palliative Care Focus: As cancer diagnoses increase globally, there is an expanding focus on palliative care, which includes pain management as a core component. Palliative care aims to improve the quality of life for patients by addressing not only physical pain but also emotional, psychological, and social needs. Healthcare providers and policymakers are prioritizing the development of palliative care programs and services to address the complex needs of cancer patients.
• Shift toward Home-based Care: Home-based care is gaining momentum in cancer pain management. Advances in telemedicine, home healthcare services, and portable pain management devices are enabling patients to receive effective treatment in their homes. This shift reduces hospital stays, lowers healthcare costs, and provides patients with the comfort of being at home during their treatment, improving overall patient satisfaction and quality of life.

These trends are reshaping the cancer pain market by offering more diversified and personalized solutions. The move away from opioids, advancements in drug delivery technologies, and the focus on holistic care are improving patient outcomes and satisfaction. Additionally, the shift to home-based and palliative care models is increasing accessibility and affordability, which is crucial for addressing the growing global cancer burden.

Recent Developments in the Cancer Pain Market

The cancer pain market is undergoing significant changes driven by technological advancements, innovative therapies, and evolving healthcare policies. These developments are enhancing the management of cancer pain and expanding access to effective treatments. Below are five key developments in the cancer pain market that are influencing its growth and direction.

• Development of Non-Opioid Pain Management Options: The increasing awareness of the risks associated with opioid use has led to the development of non-opioid pain management alternatives. These alternatives include nerve block treatments, nerve growth factor inhibitors, and cannabinoids, offering effective pain relief with fewer side effects. The shift to these options is expected to reduce opioid dependence and improve overall pain management for cancer patients.
• Advancements in Pain Management Devices: Technological innovations have resulted in the development of advanced pain management devices, such as neurostimulation and spinal cord stimulators. These devices are being used to treat refractory cancer pain and offer patients more options beyond traditional drug therapies. The growing popularity of these devices is contributing to a more personalized approach to pain management.
• Regulatory Improvements in Pain Management Access: In several regions, including the United States and Europe, regulatory changes are being implemented to improve access to cancer pain management solutions. Policies focusing on expanding opioid access, approving new non-opioid therapies, and enhancing reimbursement mechanisms are making it easier for patients to access the treatments they need.
• Innovations in Combination Therapies: The trend toward combination therapies, which combine pharmacological treatments with non-pharmacological interventions, is gaining momentum. These therapies address multiple aspects of cancer pain and provide patients with more comprehensive treatment options. For example, combining opioid medications with acupuncture or physical therapy can enhance pain relief and improve quality of life.
• Integration of Telemedicine in Pain Management: Telemedicine is transforming cancer pain management by allowing healthcare providers to monitor patients remotely and provide real-time adjustments to treatment plans. This development is particularly beneficial for patients in rural or underserved areas, making pain management more accessible. The integration of telemedicine also improves patient engagement and compliance with treatment regimens.

These key developments are enhancing the cancer pain management landscape by providing more effective, personalized, and accessible treatment options. As a result, patients are experiencing better pain relief and improved quality of life, while healthcare systems benefit from more cost-effective solutions.

Strategic Growth Opportunities in the Cancer Pain Market

The cancer pain market offers significant growth opportunities, particularly in response to the growing global incidence of cancer and the evolving needs of patients. Key applications such as pharmaceuticals, medical devices, and palliative care are critical areas where strategic growth can be achieved. Below are five key growth opportunities by application that are shaping the future of cancer pain management.

• Pharmaceutical Advancements: The development of new pain-relief medications, particularly non-opioid analgesics, presents significant growth opportunities. With increasing concerns over opioid misuse, pharmaceutical companies are focusing on alternatives such as cannabinoids, anti-depressants, and local anesthetics. Innovations in these medications could provide more effective and safer options for managing cancer pain.
• Medical Devices for Pain Management: The medical devices segment, including transdermal drug delivery systems, neurostimulation, and implantable pumps, is seeing rapid growth. These devices allow for targeted pain relief, reducing side effects and improving patient quality of life. As technology improves, there will be further opportunities to develop more efficient and user-friendly devices for cancer pain management.
• Palliative Care Programs: With the rising demand for compassionate care, there is a growing opportunity to develop comprehensive palliative care programs. These programs not only focus on pain management but also address the emotional, psychological, and spiritual needs of cancer patients. Investment in such programs can help healthcare providers offer holistic care, improving patient outcomes and satisfaction.
• Telemedicine and Home Care Solutions: The expansion of telemedicine and home-based care services presents an opportunity to reach more patients with cancer pain, especially those in remote or underserved areas. By offering remote consultations and monitoring, healthcare providers can deliver continuous care, ensuring timely adjustments to pain management treatments.
• Oncology-focused Pain Clinics: Specialized oncology pain clinics are emerging as a key opportunity for growth. These clinics provide expert, multi-disciplinary care to cancer patients suffering from pain, offering tailored treatments that address the complexity of cancer pain. The rise in such specialized clinics is an important trend in providing comprehensive care.

These growth opportunities are reshaping the cancer pain market by enhancing access to more personalized, effective, and holistic treatment options. The focus on innovation in drugs, devices, palliative care, and telemedicine is improving patient outcomes and satisfaction while opening new avenues for market expansion.

Cancer Pain Market Driver and Challenges

The cancer pain market is driven by a variety of technological, economic, and regulatory factors, but it also faces several challenges that impact its growth. Understanding the key drivers and challenges is crucial for stakeholders in the healthcare industry to navigate and capitalize on market opportunities. Below are the main drivers and challenges impacting the cancer pain market.

The factors responsible for driving the cancer pain market include:

1. Technological Advancements: New technologies in drug delivery systems, pain management devices, and diagnostic tools are transforming the cancer pain market. Innovations such as personalized pain management and neurostimulation devices are driving market growth by providing more targeted and effective treatments for cancer pain.

2. Increasing Cancer Prevalence: The rising global incidence of cancer is a major driver of the cancer pain market. As the number of cancer patients increases, so does the demand for pain management solutions. This trend is particularly prominent in aging populations, where cancer-related pain management becomes an even more critical need.

3. Opioid Crisis and Shift to Non-Opioid Alternatives: The growing concerns over opioid misuse and addiction are driving the demand for non-opioid alternatives for cancer pain relief. This shift is encouraging research and development in non-opioid medications, as well as alternative pain management therapies such as nerve blocks and acupuncture.

4. Healthcare System Advancements: Improvements in healthcare infrastructure and cancer care policies in both developed and emerging markets are enabling better access to cancer pain management solutions. This includes better insurance coverage, reimbursement policies, and government support for cancer care services.

5. Rising Patient Awareness and Demand for Better Pain Management: Increased awareness among patients and healthcare providers about the importance of managing cancer pain has led to higher demand for effective treatments. This demand is driving innovation in pain management strategies and fueling market growth.

Challenges in the cancer pain market are:

1. Access to Opioids and Pain Management in Developing Regions: Limited access to opioids and other pain management therapies in developing regions remains a significant challenge. Regulatory restrictions, supply chain issues, and cultural stigmas around pain management hinder the ability of patients in these regions to receive adequate care.

2. High Treatment Costs: The high cost of advanced pain management therapies, including certain medications and medical devices, remains a barrier for many patients, especially in low-income and middle-income countries. This limits the affordability and accessibility of effective cancer pain treatments.

3. Lack of Awareness in Rural Areas: In many parts of the world, particularly rural areas, there is a lack of awareness about cancer pain management options. This results in underdiagnosis and undertreatment of cancer pain, negatively impacting patient outcomes.

The cancer pain market is experiencing rapid growth driven by technological innovations, increasing cancer prevalence, and the shift toward non-opioid pain management. However, challenges such as access to treatments in developing regions, high treatment costs, and lack of awareness remain key barriers to market expansion. Addressing these challenges will be crucial for ensuring that cancer patients worldwide receive effective pain management.

List of Cancer Pain Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cancer pain companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cancer pain companies profiled in this report include-

• BioDelivery Science
• ProStrakan Group
• Teva Pharmaceuticals
• Eli-Lilly
• Grunenthal Group
• GW Pharmaceuticals
• Johnson&Johnson
• Meda Pharmaceuticals
• Orexo
• Sanofi

Cancer Pain Market by Segment

The study includes a forecast for the global cancer pain market by type, application, and region.

Cancer Pain Market by Type [Value from 2019 to 2031]:

• Opioids
• Non-Steroidal Anti-Inflammatory Drugs
• Others

Cancer Pain Market by Application [Value from 2019 to 2031]:

• Radiotherapy
• Chemotherapy
• Hormone Therapy
• Others

Cancer Pain Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Cancer Pain Market

Cancer pain is a significant issue for cancer patients worldwide, with many facing both acute and chronic pain as a result of the disease and its treatments. The market for cancer pain management includes various therapies, including pharmaceutical options, medical devices, and alternative treatments. Over the years, advancements in drug formulations, the introduction of innovative therapies, and the growing awareness around cancer pain management have propelled the market forward. This document explores the key recent developments, emerging trends, growth opportunities, and the drivers and challenges affecting the cancer pain market in different regions, including the United States, China, Germany, India, and Japan.

• United States: The United States has seen significant advancements in the cancer pain market, with increased adoption of new drug formulations and the development of innovative pain management technologies. Key players in the pharmaceutical sector are focusing on improving opioid alternatives to address both efficacy and safety concerns. Non-opioid pain management strategies, such as the use of cannabinoids, nerve blocks, and personalized treatments, are gaining traction. Additionally, regulatory efforts and reimbursement policies have improved access to pain relief for cancer patients, fostering market growth.
• China: The Chinese cancer pain market is experiencing rapid growth, driven by the country's increasing cancer incidence and healthcare advancements. New analgesic drugs, particularly opioid and non-opioid alternatives, are becoming more widely available. The government's focus on improving healthcare infrastructure and enhancing cancer care services is helping address pain management needs. However, there are still challenges in reaching underserved rural areas and overcoming cultural stigmas surrounding pain management. Overall, the Chinese market is witnessing a growing demand for pain relief solutions as awareness of cancer pain treatment expands.
• Germany: The German cancer pain market is characterized by high-quality healthcare services and the widespread adoption of advanced treatment options. The country has seen a rise in the use of multi-modal pain management strategies, including pharmacological and non-pharmacological treatments. The increasing preference for targeted therapies and combination therapies for cancer pain has influenced market growth. The government's strong regulatory frameworks and comprehensive insurance systems have also helped improve access to pain management services, contributing to the overall growth of the market.
• India: The Indian cancer pain market is evolving due to a rising cancer burden and improved healthcare access, especially in urban areas. While the market faces challenges such as opioid access restrictions and insufficient awareness, there have been notable advancements in pain management through the use of non-opioid alternatives, such as nerve blocks and palliative care programs. The development of low-cost generic analgesics is helping make cancer pain management more affordable. Furthermore, increased focus on healthcare policy reforms and infrastructure improvements is expected to accelerate the growth of the market in India.
• Japan: Japan is witnessing steady growth in the cancer pain management market, driven by the aging population and advancements in medical technology. There is a strong focus on improving personalized cancer care, with new drug delivery systems, including slow-release formulations, being developed for long-term pain management. The government is also investing in expanding palliative care services and supporting research into alternative pain management options, such as non-pharmacological therapies. The Japanese market's growth is also fueled by an increased public and healthcare provider awareness about cancer pain.

Features of the Global Cancer Pain Market

• Market Size Estimates: Cancer pain market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Cancer pain market size by type, application, and region in terms of value ($B).
• Regional Analysis: Cancer pain market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the cancer pain market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cancer pain market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the cancer pain market by type (opioids, non-steroidal anti-inflammatory drugs, and others), application (radiotherapy, chemotherapy, hormone therapy, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cancer Pain Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: PESTLE Analysis
• 2.4: Patent Analysis
• 2.5: Regulatory Environment
• 2.6: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Cancer Pain Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Cancer Pain Market by Type
  • 3.3.1: Opioids: Trends and Forecast (2019 to 2031)
  • 3.3.2: Non-Steroidal Anti-Inflammatory Drugs: Trends and Forecast (2019 to 2031)
  • 3.3.3: Others: Trends and Forecast (2019 to 2031)
• 3.4: Global Cancer Pain Market by Application
  • 3.4.1: Radiotherapy: Trends and Forecast (2019 to 2031)
  • 3.4.2: Chemotherapy: Trends and Forecast (2019 to 2031)
  • 3.4.3: Hormone Therapy: Trends and Forecast (2019 to 2031)
  • 3.4.4: Others: Trends and Forecast (2019 to 2031)

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Cancer Pain Market by Region
• 4.2: North American Cancer Pain Market
  • 4.2.1: North American Market by Type: Opioids, Non-Steroidal Anti-Inflammatory Drugs, and Others
  • 4.2.2: North American Market by Application: Radiotherapy, Chemotherapy, Hormone Therapy, and Others
  • 4.2.3: The United States Cancer Pain Market
  • 4.2.4: Mexican Cancer Pain Market
  • 4.2.5: Canadian Cancer Pain Market
• 4.3: European Cancer Pain Market
  • 4.3.1: European Market by Type: Opioids, Non-Steroidal Anti-Inflammatory Drugs, and Others
  • 4.3.2: European Market by Application: Radiotherapy, Chemotherapy, Hormone Therapy, and Others
  • 4.3.3: German Cancer Pain Market
  • 4.3.4: French Cancer Pain Market
  • 4.3.5: Spanish Cancer Pain Market
  • 4.3.6: Italian Cancer Pain Market
  • 4.3.7: The United Kingdom Cancer Pain Market
• 4.4: APAC Cancer Pain Market
  • 4.4.1: APAC Market by Type: Opioids, Non-Steroidal Anti-Inflammatory Drugs, and Others
  • 4.4.2: APAC Market by Application: Radiotherapy, Chemotherapy, Hormone Therapy, and Others
  • 4.4.3: Japanese Cancer Pain Market
  • 4.4.4: Indian Cancer Pain Market
  • 4.4.5: Chinese Cancer Pain Market
  • 4.4.6: South Korean Cancer Pain Market
  • 4.4.7: Indonesian Cancer Pain Market
• 4.5: ROW Cancer Pain Market
  • 4.5.1: ROW Market by Type: Opioids, Non-Steroidal Anti-Inflammatory Drugs, and Others
  • 4.5.2: ROW Market by Application: Radiotherapy, Chemotherapy, Hormone Therapy, and Others
  • 4.5.3: Middle Eastern Cancer Pain Market
  • 4.5.4: South American Cancer Pain Market
  • 4.5.5: African Cancer Pain Market

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Cancer Pain Market by Type
  • 6.1.2: Growth Opportunities for the Global Cancer Pain Market by Application
  • 6.1.3: Growth Opportunities for the Global Cancer Pain Market by Region
• 6.2: Emerging Trends in the Global Cancer Pain Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Cancer Pain Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cancer Pain Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: BioDelivery Science
  • Company Overview
  • Cancer Pain Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.2: ProStrakan Group
  • Company Overview
  • Cancer Pain Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.3: Teva Pharmaceuticals
  • Company Overview
  • Cancer Pain Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.4: Eli-Lilly
  • Company Overview
  • Cancer Pain Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.5: Grunenthal Group
  • Company Overview
  • Cancer Pain Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.6: GW Pharmaceuticals
  • Company Overview
  • Cancer Pain Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.7: Johnson&Johnson
  • Company Overview
  • Cancer Pain Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.8: Meda Pharmaceuticals
  • Company Overview
  • Cancer Pain Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.9: Orexo
  • Company Overview
  • Cancer Pain Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.10: Sanofi
  • Company Overview
  • Cancer Pain Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing